Sequencing and Bioinformatics-Based Analyses of the microRNA Transcriptome in Hepatitis B–Related Hepatocellular Carcinoma
2011

Sequencing-Based Analysis of miRNA in Liver Cancer

Sample size: 22 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mizuguchi Yoshiaki, Mishima Takuya, Yokomuro Shigeki, Arima Yasuo, Kawahigashi Yutaka, Shigehara Kengo, Kanda Tomohiro, Yoshida Hiroshi, Uchida Eiji, Tajiri Takashi, Takizawa Toshihiro

Primary Institution: Nippon Medical School, Tokyo, Japan

Hypothesis

The study investigates the role of microRNAs (miRNAs) in the progression of hepatocellular carcinoma (HCC) and their potential as biomarkers.

Conclusion

The combination of sequencing and bioinformatics can identify novel miRNAs and biomarkers associated with liver cancer.

Supporting Evidence

  • The study identified over 314,000 miRNA reads from HCC samples.
  • Seven novel miRNAs were discovered with high conservation.
  • miR-21 and miR-122 showed significant expression differences between HCC and normal liver.

Takeaway

This study looks at tiny molecules called miRNAs in liver cancer to find new ways to diagnose and treat the disease.

Methodology

The study used 454 sequencing and conventional cloning to analyze miRNA expression in liver samples from patients with HCC and adjacent normal liver.

Potential Biases

Potential biases may arise from the selection of patient samples and the methods used for miRNA detection.

Limitations

The study may not account for all variables affecting miRNA expression and relies on specific patient demographics.

Participant Demographics

Patients were positive for hepatitis B virus and had no history of alcohol abuse or other liver diseases.

Statistical Information

P-Value

0.006

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0015304

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication